Where is Regista located?

Regista is headquartered in Seattle, United States.

How many employees does Regista have?

As of Jul 01, 2024, the latest employee count at Regista is 1.

Is Regista a funded company?

Regista is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Regista rank among its competitors?

Regista ranks 46th amongst 40 active competitors, of which 10 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was NEOGAP, which secured $9.76M in Feb, 2026.

Who are the top competitors of Regista?

Regista's top competitors include Cyted, NEOGAP and Azra. Among them, NEOGAP secured the most recent funding round in February, 2026.

Regista - 2026 Company Profile & Competitors

Regista's employee count trend

Regista has 1 employees as of Jul 24. Here is Regista's employee count trend over the years:

Uncover Regista's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Regista include Cyted, NEOGAP and Azra. Here is the list of Top 10 competitors of Regista, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cyted 2018, Cambridge (United Kingdom), Series B	Leader in non-endoscopic diagnostics for digestive health, enabling early disease detection and access to care for all	$50.4M	Advent Life Sciences, EQT & 3 others	57/100
2nd	NEOGAP 2016, Stockholm (Sweden), Series A	Developer of radiopharmaceuticals for the treatment of cancer	$10.2M	Okomera, Europa & 4 others	55/100
3rd	Azra 2022, Franklin (United States), Series A	AI and machine learning to automate oncology workflows	$7.95M	FCA Venture Partners, Sopris Capital	52/100
4th	Stratipath Medical 2019, Stockholm (Sweden), Unfunded	Provider of AI-based software for cancer treatments	-	-	46/100
5th	Oncora 2014, Philadelphia (United States), Seed	AI-based clinical data analysis and decision support tool for oncologists	$3.11M	dhaphilly.com, Ben Franklin Technology Partners ... & 4 others	44/100
6th	AliveX 2019, Zurich (Switzerland), Seed	Provider of an AI-based diagnostic platform for oncology and autoimmune diseases	-	5Y Capital, K2VC & 1 others	38/100
7th	Cambridge Cancer Genomics 2015, Cambridge (United Kingdom), Acqui-Hired	Developer of AI-based precision medicine tools for oncologists	$4.62M	AME Cloud Ventures, Y Combinator & 13 others	37/100
8th	CADESS 2016, Uppsala (Sweden), Seed	AI based decision support solution for healthcare professionals	-	Almi Invest, Vinnova & 3 others	32/100
9th	PreView Medical 2020, Longmont (United States), Funding Raised	Provider of an AI-based optical diagnostic tool for cancer treatment	-	Kyto Technology & Life Science, SeedFolio ... & 1 others	29/100
10th	MRImath 1980, Birmingham (United States), Early Stage	Provider of AI-based platform to improve cancer diagnosis and care	$200K	Rowan University	28/100
46th	Regista 2019, Seattle (United States), Unfunded	Provider of an AI-based technology for early cancer prevention and treatment	-	-	15/100